Purchase Order 75N98026P01147
Award Date 7/30/26
Potential Completion Date 7/29/27
Potential Value $87K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Virginia Beach, VA 23453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $11,525 purchase order to Lifenet Health of Virginia Beach, Virginia. The firm fixed price order is to acquire superior grade primary hepatocytes to support cell-based assay studies for the agency's Malnutrition Project between June 29th and July 31st, 2023. No additional context on vehicle contracts or set aside designations was provided. The award utilizes a streamlined...
- The U.S. Office of Research and Development awarded a $216,000 firm fixed-price purchase order to Lifenet Health for the preparation and delivery of human thyroid epithelial cells, with performance in Virginia Beach, Virginia. The contract, which commenced on November 17, 2020, includes a base year plus four option years with an ultimate completion date of November 17, 2025. This procurement supported the government's research and development initiatives by securing specialized cellular...
- This $25,100 firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA) to Lifenet Health, a non-profit organization and manufacturer of regenerative medicine products, to conduct 3D liver spheroid assays for pharmacogenomics-based prediction of drug-induced liver injury (DILI). The award has a period of performance through September 29, 2025 and was not set aside for any particular business type. Lifenet Health is a specialized provider of human tissues and...
- The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $139,030 purchase order to Lifenet Health of Virginia Beach, Virginia. Under the firm fixed price contract, Lifenet Health will provide a single organ standard system to support the agency's research efforts from August 2023 through January 2024. As the prime contractor, Lifenet Health will deliver its LIFENET HEALTH - OOC SINGLE ORGAN STANDARD SYSTEM to the...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
- The Food and Drug Administration has awarded a $244K delivery order to Lifenet Health, a Virginia Beach-based nonprofit manufacturer specializing in regenerative medicine products and human tissue distribution for transplantation and research. Issued on September 22, 2025, with a completion date of September 30, 2027, this firm fixed-price delivery order covers the Iontox Multi-Organ In Vitro System and represents a non-set-aside competitive award. The contract is executed under the Medical...
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- <p>The Food and Drug Administration issued a purchase order to Bioivt, LLC on July 30, 2026, for metabolism-qualified cryopreserved human hepatocytes, with a ceiling value of $33,510.10 and a firm fixed price. Performance occurs in Silver Spring, Maryland, with ultimate completion by January 29, 2027. No set-aside applied to this commercial acquisition.</p>